证券代码：834033 证券简称：康普化学 公告编号：2024-097 重庆康普化学工业股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、基本情况概述 为满足日常经营需要，重庆康普化学工业股份有限公司（以下简称"公 司"）拟向中国工商银行股份有限公司重庆长寿支行申请流动资金贷款人民币 4,000 万元整，担保方式为信用，贷款期限为 12 个月。具体提款方式、金额等 以后续签订的借款合同为准。 二、审议情况 公司于 2024 年 11 月 5 日召开第四届董事会第六次会议，审议通过了《关 于拟向银行申请流动资金贷款的议案》。表决结果如下：同意 5 票，反对 0 票，弃权 0 票。 根据《北京证券交易所股票上市规则（试行）》及《公司章程》等相关规 定，本次向银行申请流动资金贷款事项在董事会的审议范围及权限内，无需提 交股东大会审议。 关于拟向银行申请流动资金贷款的公告 四、备查文件 《重庆康普化学工业股份有限公司第四届董事会第六次会议决议》。 特此公告。 重庆康普化学工业股份有限公司 三、对 ...

证券代码：834033 证券简称：康普化学 公告编号：2024-096 重庆康普化学工业股份有限公司 第四届董事会第六次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 11 月 5 日 2.会议召开地点：公司会议室 3.会议召开方式：现场与通讯方式召开 4.发出董事会会议通知的时间和方式：2024 年 11 月 1 日以通讯方式发出 5.会议主持人：董事长邹潜先生 6.会议列席人员：监事、其他高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开及议案审议程序符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 5 人，出席和授权出席董事 5 人。 董事周涛因工作原因以通讯方式参与表决。 董事程世红因工作原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于拟向银行申请流动资金贷款的议案》 1.议案内容： 为满足日常经营需要，公司拟向 ...

Group 1: Investor Relations Activity Overview - The investor relations activity was conducted via a conference call from October 25 to October 29, 2024 [2] - Participants included various securities firms and investment funds, with the company represented by the chairman and financial officers [2] Group 2: Key Questions and Responses - The purpose of the 100-ton level green comprehensive utilization facility for retired battery metals is to prepare for urban mining resource utilization and validate new hydrometallurgical technology [3] - The main growth points for the next two years will come from the "20,000 tons/year special surfactant production project," which is in trial production and expected to gradually release capacity [4] - The mineral flotation agent is still in trial production, with customer validation ongoing [5] - Sales of acid mist suppressants have matched last year's total sales by mid-year, maintaining strong sales in Q3 [6] - The official listing of the China Resource Recycling Group is seen as a positive influence, aligning with the company's resource recycling strategy [7] - Q3 revenue decline was attributed to decreased demand for copper extraction agents from key customers [8] Group 3: Financial Performance Insights - As of Q3 2024, accounts receivable increased by 106.82% to CNY 148.82 million, primarily due to the transfer of warranty deposits from contract assets [10] - Inventory increased by 45.38% to CNY 195.96 million, mainly in semi-finished products, due to low core raw material prices and increased stock to meet customer demand [11] - Financial expenses fluctuated significantly due to reduced average deposit balances and foreign currency settlement impacts [12] - Contract liabilities decreased by 66.52% to CNY 3.38 million, mainly due to reduced demand from key customers [13]

Group 1: Investor Relations Activity Overview - The investor relations activity was conducted via a conference call from October 25 to October 29, 2024 [2] - Participants included various securities firms and investment funds, with a total of 50 entities represented [2] Group 2: Key Questions and Responses - The purpose of the 100-ton level green comprehensive utilization facility for retired battery metals is to prepare for urban mining resource utilization and validate new hydrometallurgical technology [3] - The main growth drivers for the next two years will come from the "20,000 tons/year special surfactant production project," which is currently in trial production [4] - The mineral flotation agent is still in trial production, with customer validation ongoing [5] - Sales of acid mist suppressants have matched last year's total sales by mid-year, maintaining strong sales in Q3 [6] Group 3: Financial Performance Insights - Q3 revenue declined due to decreased demand for copper extraction agents from key customers [8] - Accounts receivable increased by 106.82% to 148.82 million yuan due to the transfer of warranty deposits from contract assets [10] - Inventory rose by 45.38% to 195.96 million yuan, primarily in semi-finished products, to meet customer demand [11] - Financial expenses fluctuated significantly due to reduced interest income from lower average deposits and foreign currency settlement impacts [12] Group 4: Contract Liabilities and Depreciation - Contract liabilities decreased by 66.52% to 3.38 million yuan, attributed to reduced demand from major customers [13] - Depreciation and amortization expenses are expected to increase due to the completion of the "Kangpu Chemical Technology Research Institute" project and the "20,000 tons/year special surfactant production project" [9]

证券代码：834033 证券简称：康普化学 公告编号：2024-095 重庆康普化学工业股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 活动时间：2024 年 10 月 25 日至 2024 年 10 月 29 日 □特定对象调研 □业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 （电话会议） 二、 投资者关系活动情况 活动地点：电话会议 参会单位及人员：申万宏源、润晖投资、东北证券、中信证券、国海证券、 创金合信基金、紫阁资本、国泰君安、第一创业证券、圆石投资、合远私募基金、 开源证券、长江证券、平安证券、国投证券、中信建投基金、宝盈基金、广发基 金、中天汇富基金、中杰投资、长乐汇、叶海睿德、乾和资产、泰石投资、四海 圆通、前海互兴、万丰友方、盟洋投资、汇瑾资产、度势投资、递归私募、冰河 资产、南土资产、巨鹿投资、华鑫证券、华杉投资、汉享投资、国寿养老、星允 投资、青创伯乐、德睿恒丰、东吴证券、红土创新、 ...

Investment Rating - The investment rating for the company is "Outperform" [6] Core Insights - The company reported lower-than-expected performance in Q3 2024, with revenue of 285 million yuan, down 17.4% year-on-year, and a net profit of 79.25 million yuan, down 30.8% year-on-year [6] - The decline in revenue is attributed to a lack of new demand for copper extraction agents, while the gross margin remains high at 44.8%, supported by increased sales of high-margin lithium extraction agents [6] - The establishment of a new technical research institute has led to increased management and technical personnel costs, impacting overall expenses [6] - An employee stock ownership plan was announced, reflecting the company's confidence in long-term stable development [6] - The company is well-positioned to enter the lithium battery and urban mining resource recovery sectors, aligning with national policy directions [6] Financial Summary - For the first three quarters of 2024, the company achieved a revenue of 285 million yuan, with a year-on-year decline of 17.4% [7] - The net profit for the same period was 79 million yuan, down 30.8% year-on-year, with a net profit margin of 27.8% [6][7] - The company expects to achieve net profits of 107 million yuan, 118 million yuan, and 137 million yuan for 2024, 2025, and 2026 respectively, with corresponding PE ratios of 28, 26, and 22 [6][7] Market Comparison - The company's stock price has shown a significant decline compared to the market index, with a one-year high of 50.50 yuan and a low of 14.03 yuan [2] - The current market capitalization is approximately 2.107 billion yuan [2]

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Views - The company's performance and cash flow are under pressure due to declining downstream market demand, with a year-on-year revenue decrease of 17.38% for the first three quarters of 2024 [2] - The gross profit margin improved year-on-year to 44.82%, while the operating expenses ratio increased [2] - The special surfactant project has entered trial production, and an employee stock ownership plan was launched to enhance incentives [2] Financial Performance Summary - For 2024, the company is expected to generate total revenue of 3.9434 billion yuan, a decrease of 10.76% year-on-year, with a net profit attributable to shareholders of 1.2795 billion yuan, down 14.59% year-on-year [3] - The latest diluted EPS is projected at 1.07 yuan per share for 2024, with a P/E ratio of 13.68 [3] - The company reported a net cash flow from operating activities of -0.27 billion yuan for the first three quarters of 2024, a significant decline of 134.66% year-on-year [2][9] Market Data - The closing price of the company's stock is 26.05 yuan, with a market capitalization of 3.10347 billion yuan [5] - The company has a price-to-book ratio of 4.32 [5] Basic Data - The company's total assets are projected to reach 953 million yuan in 2024, with a debt-to-asset ratio of 16.73% [6][8]

证券代码：834033 证券简称：康普化学 公告编号：2024-093 重庆康普化学工业股份有限公司 第四届监事会第五次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 本次会议的召集、召开及议案审议程序符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 1.议案内容： 公司根据 2024 年第三季度实际经营情况以及有关业务规则的要求，编制了 1.会议召开时间：2024 年 10 月 24 日 2.会议召开地点：公司会议室 3.会议召开方式：现场与通讯方式 4.发出监事会会议通知的时间和方式：2024 年 10 月 21 日以通讯方式发出 5.会议主持人：监事会主席潘玮先生 6.召开情况合法、合规、合章程性说明： 《2024 年第三季度报告》。 具体内容详见公司于 2024 年 10 月 24 日在北京证券交易所信息披露平台 （http://www.bse.cn/）披露的《2024 年第三季度报告》（2024-094）。 2.议案 ...

证券代码：834033 证券简称：康普化学 公告编号：2024-092 重庆康普化学工业股份有限公司 第四届董事会第五次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 10 月 24 日 2.会议召开地点：公司会议室 二、议案审议情况 （一）审议通过《关于公司 2024 年第三季度报告的议案》 1.议案内容： 3.会议召开方式：现场与通讯方式召开 4.发出董事会会议通知的时间和方式：2024 年 10 月 21 日以通讯方式发出 5.会议主持人：董事长邹潜先生 6.会议列席人员：其他高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开及议案审议程序符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 5 人，出席和授权出席董事 5 人。 董事周涛因工作原因以通讯方式参与表决。 董事程世红因工作原因以通讯方式参与表决。 公司根据 2024 年第 ...

本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 证券代码：834033 证券简称：康普化学 公告编号：2024-093 重庆康普化学工业股份有限公司 第四届监事会第五次会议决议公告 《2024 年第三季度报告》。 具体内容详见公司于 2024 年 10 月 24 日在北京证券交易所信息披露平台 （http://www.bse.cn/）披露的《2024 年第三季度报告》（2024-094）。 2.议案表决结果：同意 3 票；反对 0 票；弃权 0 票。 3.回避表决情况 本次会议的召集、召开及议案审议程序符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 监事周放历因工作原因以通讯方式参与表决。 二、议案审议情况 （一）审议通过《关于公司 2024 年第三季度报告的议案》 1.议案内容： 公司根据 2024 年第三季度实际经营情况以及有关业务规则的要求，编制了 1.会议召 ...